Akers Biosciences Inc Profit Margin 2012-2020 | AKER
Current and historical gross margin, operating margin and net profit margin for Akers Biosciences Inc (AKER) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Akers Biosciences Inc net profit margin as of March 31, 2020 is -489.84%.
|Akers Biosciences Inc Annual Profit Margins
|Akers Biosciences Inc Quarterly Profit Margins
||Medical Products Manufacturing
Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.